Patients must sign an informed consent prior to registration and before undergoing any study-specific procedures indicating that they are aware of the investigational nature of this study
Patients must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects; patients will be given a copy of the consent form
Patients must sign a document that indicates that they are aware of the investigative nature of the treatment of this protocol, and the potential benefits and risks; patients unwilling or unable due to cognitive impairment to sign informed consent are excluded from the study
Patients must have signed informed consent indicating that they are aware of the investigational nature of the study, and are aware that participation is voluntary; patients must be made aware of their other treatment options
Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution. Patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy.
Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution. Patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy
All patients must sign informed consent verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of MD Anderson Cancer Center; the only acceptable consent is the one approved by MD Anderson Institutional Review Board (IRB)
All patients must be capable to voluntarily sign an informed consent indicating that they are aware of the investigational nature of this study prior to registration
All patients must sign informed consent forms verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of MD Anderson Cancer Center; the only acceptable consent form is one approved by the MD Anderson institutional review board
Patients must sign an informed consent indicating they are aware of the investigational nature of this study, in keeping with the policies of the hospital
Patients must sign an informed consent form indicating that they are aware of the investigational nature of this study, in keeping with the policies of the hospital
Patients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved
Patients must have signed informed consent indicating that they are aware of the investigational nature of the study, and are aware that participation is voluntary
Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution; patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy
Patients must sign an informed consent document that indicates they are aware of the investigational nature of the treatment in this protocol as well as the potential risks and benefits
Be aware of the nature of her malignancy
Patients must sign an informed consent document that indicates they are aware of the investigational nature of the treatment in this protocol as well as the potential risks and benefits
Willing to sign an informed consent form, indicating awareness of the investigational nature of this study that is in keeping with the policies of the institution.
Patients must be aware of the investigational nature of the therapy and provide written informed consent
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study
Patients must be able to understand and sign an informed consent indicating that they are aware of the investigational nature of this study in keeping with the institutional policies.
Patients must be aware of the investigational nature of the therapy and provide written informed consent
Patients must sign an informed consent indicating that they are aware of the investigational nature of the study in keeping with the policy of MD Anderson Cancer Center (MDACC)
All patients must sign informed consent verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of M.D. Anderson Cancer Center; the only acceptable consent form is the one attached at the end of this protocol, and it must have been approved and amended by the M.D. Anderson Institutional Review Board (IRB)
Patients must voluntarily sign an informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of the hospital
Patients must sign the current institutional review board (IRB) approved informed consent indicating that they are aware of the investigational nature of this study, in keeping with the policies of the institution, and willing and able to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Ability to understand and the willingness to sign a written informed consent document indicating that they are aware of the investigational nature of the study
Patients must sign informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of the hospital.
Patients must sign an informed consent document that indicates they are aware of the investigative nature of the treatment in this protocol as well as the potential risks and benefits
Patients must be able to read and understand the informed consent document; patients must sign the informed consent indicating that they are aware of the investigational nature of this study
Signed informed consent indicating that patients are aware of the investigational nature of this study in keeping with the policies of University of Texas M.D. Anderson Cancer Center (UTMDACC)
Patients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study
Patients must sign an informed consent prior to registration and before undergoing any study-specific procedures indicating that they are aware of the investigational nature of this study
All patients must sign informed consent verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of MD Anderson Cancer Center; the only acceptable consent form is the one approved by MD Anderson institutional review board (IRB)
All patients must sign a consent form indicating that they are aware of the investigational nature of the study; the informed consent form will indicate that the patient has been made aware of all other appropriate therapies
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study.
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must be registered prior to treatment with study drug
Sign the current Institutional Review Board (IRB) approved informed consent indicating that they are aware of the investigational nature of this study, in keeping with the policies of the institution
Patients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved
Patients must sign an informed consent form indicating that they are aware of the investigational nature of this study, in keeping with the policies of the hospital
Patients must sign informed consent indicating that they are aware of the investigational nature of this study according to the policies of the MD Anderson Cancer Center (MDACC) Institutional Review Board (IRB)
Patients must sign an informed consent indicating they are aware of the investigational nature of this study, in keeping with the policies of the hospital
Signed informed consent indicating that patients are aware of the investigational nature of this study, in keeping with the policies of MD Anderson Cancer Center (MDACC), must be obtained prior to any study specific procedures
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of this hospital.
Patients must sign an informed consent indicating that they are aware of the investigational nature of the study
Patients must sign an Informed Consent and Authorization indicating that they are aware of the investigational nature of this study and the known risks involved
Patients must sign an informed consent indicating that they are aware of the investigational nature of this study.
All patients must sign an informed consent document indicating that they are aware of the investigational nature of this study
Sign an informed consent indicating they are aware of the investigational nature of this study
All patients must sign informed consent verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of M.D. Anderson Cancer Center; the only acceptable consent is the one approved by M.D. Anderson Institutional Review Board (IRB)
Patients unable to give informed consent indicating they are aware of the investigational nature of this intervention prior to entry into the study
SCREENING PHASE: The patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form
INTERVENTION PHASE: The patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form
The patient must be aware of the high risk and experimental nature of the treatment and provide informed consent
The patient is aware of the nature of her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent document
Patients must sign an informed consent indicating that they are aware of the investigational nature of this study, in keeping with the policies of the cancer center
Patients must sign an informed consent indicating that they are aware of the investigational nature of this study, in keeping with the policies of University of Michigan (UM) hospital
The patient is aware of the nature of her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form
Ability of subject to understand and the willingness to sign a written informed consent document indicating that they are aware of the investigational nature of this study, and that this is not a therapeutic clinical trial
